{"id":353199,"date":"2026-11-18T15:51:22","date_gmt":"2026-11-18T10:21:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353199"},"modified":"2026-11-18T15:51:22","modified_gmt":"2026-11-18T10:21:22","slug":"corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/","title":{"rendered":"3 Corn Starch Processor, Formulations Maker and Gold Jewellery Chain Stocks With a Strong Future Roadmap: Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India: ROE of 14.2% to 21.4% and FY22 to FY26 revenue CAGR of 5.4% to 34.9%. Prices as of 17 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>maize starch, generic drug and jewellery stocks<\/strong> to watch are <strong>Gujarat Ambuja Exports<\/strong>, <strong>Strides Pharma Science<\/strong> and <strong>Kalyan Jewellers India<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>14.2% to 21.4%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 5.4% to 34.9%. Kalyan Jewellers India leads on both return on equity at 21.4% and revenue growth at 34.9% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Maize starch, generic drug and jewellery stocks give investors a way to track businesses that sit close to everyday demand in India. Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India cover an agro processing company, a generic medicines maker and a jewellery retailer.<\/p>\n<p>This list covers three maize starch, generic drug and jewellery stocks with complete current figures: Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#What_Are_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"What Are Maize Starch, Generic Drug and Jewellery Stocks?\">What Are Maize Starch, Generic Drug and Jewellery Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Maize_Starch_Generic_Drug_and_Jewellery_Stocks_at_a_Glance\" title=\"Maize Starch, Generic Drug and Jewellery Stocks at a Glance\">Maize Starch, Generic Drug and Jewellery Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Why_Do_Maize_Starch_Generic_Drug_and_Jewellery_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Maize Starch, Generic Drug and Jewellery Stocks Have a Strong Roadmap in India?\">Why Do Maize Starch, Generic Drug and Jewellery Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Why_Gujarat_Ambuja_Exports_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"Why Gujarat Ambuja Exports Features Among These Maize Starch, Generic Drug and Jewellery Stocks\">Why Gujarat Ambuja Exports Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Why_Strides_Pharma_Science_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"Why Strides Pharma Science Features Among These Maize Starch, Generic Drug and Jewellery Stocks\">Why Strides Pharma Science Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Why_Kalyan_Jewellers_India_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"Why Kalyan Jewellers India Features Among These Maize Starch, Generic Drug and Jewellery Stocks\">Why Kalyan Jewellers India Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Gujarat_Ambuja_Exports_vs_Strides_Pharma_Science_vs_Kalyan_Jewellers_India_on_Key_Financials\" title=\"Gujarat Ambuja Exports vs Strides Pharma Science vs Kalyan Jewellers India on Key Financials\">Gujarat Ambuja Exports vs Strides Pharma Science vs Kalyan Jewellers India on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Key_Risks_to_Check_Before_Investing_in_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"Key Risks to Check Before Investing in Maize Starch, Generic Drug and Jewellery Stocks\">Key Risks to Check Before Investing in Maize Starch, Generic Drug and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Final_Thoughts_on_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\" title=\"Final Thoughts on Maize Starch, Generic Drug and Jewellery Stocks\">Final Thoughts on Maize Starch, Generic Drug and Jewellery Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#What_are_maize_starch_generic_drug_and_jewellery_stocks\" title=\"What are maize starch, generic drug and jewellery stocks?\">What are maize starch, generic drug and jewellery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Which_maize_starch_generic_drug_and_jewellery_stocks_are_covered_in_this_list\" title=\"Which maize starch, generic drug and jewellery stocks are covered in this list?\">Which maize starch, generic drug and jewellery stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Why_do_maize_starch_generic_drug_and_jewellery_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do maize starch, generic drug and jewellery stocks have a strong future roadmap in India?\">Why do maize starch, generic drug and jewellery stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#How_has_Gujarat_Ambuja_Exports_performed_financially\" title=\"How has Gujarat Ambuja Exports performed financially?\">How has Gujarat Ambuja Exports performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#How_has_Strides_Pharma_Science_performed_financially\" title=\"How has Strides Pharma Science performed financially?\">How has Strides Pharma Science performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#How_has_Kalyan_Jewellers_India_performed_financially\" title=\"How has Kalyan Jewellers India performed financially?\">How has Kalyan Jewellers India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#What_risks_should_investors_check_before_buying_maize_starch_generic_drug_and_jewellery_stocks\" title=\"What risks should investors check before buying maize starch, generic drug and jewellery stocks?\">What risks should investors check before buying maize starch, generic drug and jewellery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-roadmap-moraine-list\/#Is_this_list_of_maize_starch_generic_drug_and_jewellery_stocks_investment_advice\" title=\"Is this list of maize starch, generic drug and jewellery stocks investment advice?\">Is this list of maize starch, generic drug and jewellery stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>What Are Maize Starch, Generic Drug and Jewellery Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Maize starch, generic drug and jewellery stocks<\/strong> are listed companies that process maize into starch and edible products, make generic medicines for India and regulated markets, and sell gold and diamond jewellery through a large store network. Their earnings depend on agro commodity demand, medicine orders and jewellery demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Maize_Starch_Generic_Drug_and_Jewellery_Stocks_at_a_Glance\"><\/span><strong>Maize Starch, Generic Drug and Jewellery Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/gael\/gujarat-ambuja-exports-ltd-share-price-today\">Gujarat Ambuja Exports<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">144.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,603<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/star\/strides-pharma-science-ltd-share-price-today\">Strides Pharma Science<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">982.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,491<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.57<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/kalyankjil\/kalyan-jewellers-india-ltd-share-price-today\">Kalyan Jewellers India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">682.75<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">52,898<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">44.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.97<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a <strong>P\/E<\/strong> below their industry P\/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing maize starch, generic drug and jewellery stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Maize_Starch_Generic_Drug_and_Jewellery_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Maize Starch, Generic Drug and Jewellery Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Maize starch, generic drug and jewellery stocks have a strong roadmap in India because steady demand for processed agro products, steady demand for medicines and strong jewellery buying in festivals and weddings keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Agro processing.<\/strong> Food makers need starch and oils.<\/li>\n<li><strong>Generic medicines.<\/strong> Patients need affordable treatment.<\/li>\n<li><strong>Jewellery.<\/strong> Families buy gold for weddings and festivals.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Gujarat_Ambuja_Exports_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>Why Gujarat Ambuja Exports Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the <strong>maize starch, generic drug and jewellery stocks<\/strong> on this list, Gujarat Ambuja Exports is an Ahmedabad-based agro-processing company that makes maize-based products such as starch and derivatives, edible oils and cotton yarn, along with wind power.<\/p>\n<p>The company has a return on equity of 14.2%, a debt to equity ratio of 0.13 and a <strong>market capitalisation<\/strong> of Rs 6,603 crore. The stock trades at a <strong>P\/E<\/strong> of 13.0, below the industry P\/E of 32.8.<\/p>\n<p>Revenue rose from Rs 4,724 crore in FY22 to Rs 5,836 crore in FY26, a compound annual growth rate of 5.4%. Net profit grew from Rs 249 crore in FY25 to Rs 304 crore in FY26, a rise of 22.1%.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding its maize processing and value-added starch products that serve food, pharma and paper customers. A mix of agro and power activities widens its sources of revenue.<\/p>\n<p><strong>What to watch:<\/strong> Follow capacity expansion, crop prices and demand from food and industrial customers.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Strides_Pharma_Science_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>Why Strides Pharma Science Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the agro processing, pharma maker and gold retail shares on this list, Strides Pharma Science, based in Bengaluru, makes finished dosage generics for the United States and other regulated markets, with oral solids and soft gel capsules as important product groups.<\/p>\n<p>Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%.<\/p>\n<p>In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.<\/p>\n<p><strong>What to watch:<\/strong> Track new US launches and the pace of price erosion in generic categories.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Kalyan_Jewellers_India_Features_Among_These_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>Why Kalyan Jewellers India Features Among These Maize Starch, Generic Drug and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Kalyan Jewellers India is a large jewellery retailer with showrooms across India and the Middle East, selling gold, diamond and studded jewellery under the Kalyan and Candere brands.<\/p>\n<p>In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%.<\/p>\n<p>Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3.<\/p>\n<p><strong>Roadmap:<\/strong> The company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.<\/p>\n<p><strong>What to watch:<\/strong> Track same-store sales, new showroom additions and gold price movements.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Gujarat_Ambuja_Exports_vs_Strides_Pharma_Science_vs_Kalyan_Jewellers_India_on_Key_Financials\"><\/span><strong>Gujarat Ambuja Exports vs Strides Pharma Science vs Kalyan Jewellers India on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three maize starch, generic drug and jewellery stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Gujarat Ambuja Exports<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,724<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,836<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">304<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Strides Pharma Science<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,202<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,009<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">575<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Kalyan Jewellers India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,856<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35,951<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,350<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Kalyan Jewellers India posts the highest return on equity in this group at 21.4%. Kalyan Jewellers India combines the largest FY26 revenue at Rs 35,951 crore with the fastest revenue growth, a 34.9% compound annual rate. A useful habit with maize starch, generic drug and jewellery stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Maize Starch, Generic Drug and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these <strong>maize starch, generic drug and jewellery stocks<\/strong>, the main points are: Long-term agro processing, pharma maker and gold retail shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Commodity prices.<\/strong> Selling prices follow global and domestic markets.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter maize starch, generic drug and jewellery stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Maize_Starch_Generic_Drug_and_Jewellery_Stocks\"><\/span><strong>Final Thoughts on Maize Starch, Generic Drug and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Maize starch, generic drug and jewellery stocks work best when investors track growth, valuation and return on equity side by side. Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India each have a clear plan to grow. Based on the 17 November 2026 close, Gujarat Ambuja Exports trades at Rs 144.85, Strides Pharma Science at Rs 982.1 and Kalyan Jewellers India at Rs 682.75. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these <strong>maize starch, generic drug and jewellery stocks<\/strong> to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track maize starch, generic drug and jewellery stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_maize_starch_generic_drug_and_jewellery_stocks\"><\/span><strong>What are maize starch, generic drug and jewellery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Maize starch, generic drug and jewellery stocks are listed companies that process maize into starch and edible products, make generic medicines for India and regulated markets, and sell gold and diamond jewellery through a large store network. Their earnings depend on agro commodity demand, medicine orders and jewellery demand. This list looks at three of them, Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_maize_starch_generic_drug_and_jewellery_stocks_are_covered_in_this_list\"><\/span><strong>Which maize starch, generic drug and jewellery stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India. Based on the 17 November 2026 close, Gujarat Ambuja Exports traded at Rs 144.85, Strides Pharma Science at Rs 982.1 and Kalyan Jewellers India at Rs 682.75. Their return on equity ranges from <strong>14.2% to 21.4%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 5.4% to 34.9%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_maize_starch_generic_drug_and_jewellery_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do maize starch, generic drug and jewellery stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Maize starch, generic drug and jewellery stocks have a strong roadmap in India because steady demand for processed agro products, steady demand for medicines and strong jewellery buying in festivals and weddings keep widening the market for these companies. The main drivers are as follows. Agro processing. Food makers need starch and oils. Generic medicines. Patients need affordable treatment. Jewellery. Families buy gold for weddings and festivals. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Gujarat_Ambuja_Exports_performed_financially\"><\/span><strong>How has Gujarat Ambuja Exports performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 4,724 crore in FY22 to Rs 5,836 crore in FY26, a compound annual growth rate of 5.4%. Net profit grew from Rs 249 crore in FY25 to Rs 304 crore in FY26, a rise of 22.1%. The company has a return on equity of 14.2%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 6,603 crore. The stock trades at a P\/E of 13.0, below the industry P\/E of 32.8. Looking ahead, the company is expanding its maize processing and value-added starch products that serve food, pharma and paper customers. A mix of agro and power activities widens its sources of revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Strides_Pharma_Science_performed_financially\"><\/span><strong>How has Strides Pharma Science performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%. In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0. Looking ahead, the company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Kalyan_Jewellers_India_performed_financially\"><\/span><strong>How has Kalyan Jewellers India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%. Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%. In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3. Looking ahead, the company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_maize_starch_generic_drug_and_jewellery_stocks\"><\/span><strong>What risks should investors check before buying maize starch, generic drug and jewellery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying <strong>maize starch, generic drug and jewellery stocks<\/strong>. Commodity prices. Selling prices follow global and domestic markets. Regulatory approvals. Plant inspections and approvals can affect supplies. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_maize_starch_generic_drug_and_jewellery_stocks_investment_advice\"><\/span><strong>Is this list of maize starch, generic drug and jewellery stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are maize starch, generic drug and jewellery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Maize starch, generic drug and jewellery stocks are listed companies that process maize into starch and edible products, make generic medicines for India and regulated markets, and sell gold and diamond jewellery through a large store network. Their earnings depend on agro commodity demand, medicine orders and jewellery demand. This list looks at three of them, Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which maize starch, generic drug and jewellery stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India. Based on the 17 November 2026 close, Gujarat Ambuja Exports traded at Rs 144.85, Strides Pharma Science at Rs 982.1 and Kalyan Jewellers India at Rs 682.75. Their return on equity ranges from 14.2% to 21.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.4% to 34.9%.\"}},{\"@type\":\"Question\",\"name\":\"Why do maize starch, generic drug and jewellery stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Maize starch, generic drug and jewellery stocks have a strong roadmap in India because steady demand for processed agro products, steady demand for medicines and strong jewellery buying in festivals and weddings keep widening the market for these companies. The main drivers are as follows. Agro processing. Food makers need starch and oils. Generic medicines. Patients need affordable treatment. Jewellery. Families buy gold for weddings and festivals. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Gujarat Ambuja Exports performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 4,724 crore in FY22 to Rs 5,836 crore in FY26, a compound annual growth rate of 5.4%. Net profit grew from Rs 249 crore in FY25 to Rs 304 crore in FY26, a rise of 22.1%. The company has a return on equity of 14.2%, a debt to equity ratio of 0.13 and a market capitalisation of Rs 6,603 crore. The stock trades at a P\/E of 13.0, below the industry P\/E of 32.8. Looking ahead, the company is expanding its maize processing and value-added starch products that serve food, pharma and paper customers. A mix of agro and power activities widens its sources of revenue.\"}},{\"@type\":\"Question\",\"name\":\"How has Strides Pharma Science performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%. In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0. Looking ahead, the company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.\"}},{\"@type\":\"Question\",\"name\":\"How has Kalyan Jewellers India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%. Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%. In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3. Looking ahead, the company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying maize starch, generic drug and jewellery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying maize starch, generic drug and jewellery stocks. Commodity prices. Selling prices follow global and domestic markets. Regulatory approvals. Plant inspections and approvals can affect supplies. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of maize starch, generic drug and jewellery stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Maize Starch, Generic Drug and Jewellery Stocks with a strong future roadmap: Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":353198,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[22106,3803,25960,25963,5513,15733,25962,5518,25961,9049],"class_list":["post-353199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-agro-processing","tag-best-stocks","tag-generic-drug-and-jewellery-stocks","tag-generic-medicines-and-branded-jewellery-stocks","tag-gujarat-ambuja-exports","tag-kalyan-jewellers-india","tag-maize-products","tag-maize-starch","tag-pharma-maker-and-gold-retail-shares","tag-strides-pharma-science"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353198"],"rank_math_title":["Maize Starch, Generic Drug and Jewellery Stocks"],"rank_math_description":["Compare 3 maize starch, generic drug and jewellery stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["maize starch, generic drug and jewellery stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-corn-starch-processor-formulations-maker-and-gold-jewellery-chain-stocks-with.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353199"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353199\/revisions"}],"predecessor-version":[{"id":353200,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353199\/revisions\/353200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353198"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}